CH681203A5 - - Google Patents

Download PDF

Info

Publication number
CH681203A5
CH681203A5 CH886/89A CH88689A CH681203A5 CH 681203 A5 CH681203 A5 CH 681203A5 CH 886/89 A CH886/89 A CH 886/89A CH 88689 A CH88689 A CH 88689A CH 681203 A5 CH681203 A5 CH 681203A5
Authority
CH
Switzerland
Prior art keywords
rna
use according
nucleosides
nucleotides
nucleobases
Prior art date
Application number
CH886/89A
Other languages
German (de)
English (en)
Inventor
Frederick B Rudolph
Buren Charles T Van
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CH681203A5 publication Critical patent/CH681203A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
CH886/89A 1988-03-11 1989-03-09 CH681203A5 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16686688A 1988-03-11 1988-03-11

Publications (1)

Publication Number Publication Date
CH681203A5 true CH681203A5 (sv) 1993-02-15

Family

ID=22604997

Family Applications (1)

Application Number Title Priority Date Filing Date
CH886/89A CH681203A5 (sv) 1988-03-11 1989-03-09

Country Status (9)

Country Link
JP (1) JPH01279835A (sv)
BE (1) BE1002937A5 (sv)
CH (1) CH681203A5 (sv)
DE (1) DE3907842A1 (sv)
FR (1) FR2628320A1 (sv)
GB (1) GB2216416B (sv)
IT (1) IT1232819B (sv)
NL (1) NL8900581A (sv)
SE (1) SE8900835L (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2529605B2 (ja) * 1989-10-23 1996-08-28 株式会社大塚製薬工場 免疫賦活剤
US6136858A (en) 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
US5602109A (en) * 1994-01-10 1997-02-11 Abbott Laboratories Method to enhance the immune system of a human
US5488039A (en) * 1994-01-10 1996-01-30 Abbott Laboratories Method for the production of an enteral formula containing ribo-nucleotides
US5492899A (en) * 1994-01-10 1996-02-20 Abbott Laboratories Infant nutritional formula with ribo-nucleotides
US5700590A (en) * 1994-01-10 1997-12-23 Abbott Laboratories Nutritional formula with ribo-nucleotides
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US20030026782A1 (en) 1995-02-07 2003-02-06 Arthur M. Krieg Immunomodulatory oligonucleotides
US6706691B1 (en) 1998-07-15 2004-03-16 Board Of Regents, The University Of Texas System Immunosupportive drug sparing diet
ES2219182B1 (es) * 2003-05-12 2005-10-01 Jose Luis Concellon Martinez Procedimiento para compensar el efecto negativo en la salud de alimentos que contienen azucar refinado.

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS385291B1 (sv) * 1960-09-07 1963-05-07
SE302878B (sv) * 1960-12-29 1968-08-05 Takeda Chemical Industries Ltd
IE31924B1 (en) * 1966-12-23 1973-02-21 Merck & Co Inc Pharmaceutical compositions comprising polynucleotides
DE1617545C2 (de) * 1967-06-19 1983-11-03 Diether Prof. Dr. Bern Jachertz Verwendung von informatorischer Ribonucleinsäure als Vaccine
GB1254744A (en) * 1969-06-19 1971-11-24 Beecham Group Ltd Antiviral ribonucleic acid substance
DE1941942A1 (de) * 1969-08-18 1971-03-04 Sylven Bengt Prof Dr Neues pharmazeutisches Mittel
IT945910B (it) * 1971-04-08 1973-05-10 Erra C Spa Prodotto dietetico impiegabile quale intergratore dell alimenta zione umana con particolare riferi mento all infanzia agli stati di convalescenza di gravidanza d allat tamento e dell eta senile e procedi mento per la sua fabbricazione
US3914450A (en) * 1973-04-09 1975-10-21 Anheuser Busch Concentrated extract of yeast and processes of making same
GB1363398A (en) * 1973-03-29 1974-08-14 Yamasa Shoyu Kk Uridine-5.-monophosphate compositions
FR2353293A1 (fr) * 1976-06-03 1977-12-30 Beljanski Mirko Polyribonucleotides ayant une activite dans la genese des leucocytes et des plaquettes sanguines
FR2374911A1 (fr) * 1976-12-21 1978-07-21 Fabre Sa Pierre Adjuvants d'immunite non specifique
FR2471785A1 (fr) * 1979-12-21 1981-06-26 Fabre Sa Pierre Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
EP0107161B1 (de) * 1982-10-26 1989-08-09 CTA Finanz AG Mittel und Verfahren zur Optimierung der Gewebemasse von Organen innerhalb der genetischen Schwankungsbreite bei Menschen und Tieren
US4643992A (en) * 1982-11-09 1987-02-17 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
JPS59219235A (ja) * 1983-05-30 1984-12-10 Mitsui Toatsu Chem Inc 消化性潰瘍用剤
JPS608307A (ja) * 1983-06-28 1985-01-17 Ube Ind Ltd 補強ポリブタジエンの製造法
JPS60126220A (ja) * 1983-12-09 1985-07-05 Otsuka Pharmaceut Factory Inc 核酸成分組成物
EP0196530A3 (de) * 1985-03-26 1989-03-22 CTA Finanz AG Mittel und Verfahren zur Beschleunigung des Wachstums, zur Optimierung der Fruchtbarkeit und zur Stimulierung des Immunsystems bei Mensch und Tier
JPH0669953B2 (ja) * 1985-08-16 1994-09-07 日産化学工業株式会社 脳脊髄系神経栄養剤

Also Published As

Publication number Publication date
SE8900835D0 (sv) 1989-03-09
JPH01279835A (ja) 1989-11-10
SE8900835L (sv) 1989-09-12
DE3907842A1 (de) 1989-09-21
IT1232819B (it) 1992-03-05
GB2216416A (en) 1989-10-11
BE1002937A5 (fr) 1991-09-03
IT8947733A0 (it) 1989-03-10
GB2216416B (en) 1992-06-24
NL8900581A (nl) 1989-10-02
FR2628320A1 (fr) 1989-09-15
GB8905179D0 (en) 1989-04-19

Similar Documents

Publication Publication Date Title
DE60037578T2 (de) Verwendung von triacetyluridin zur behandlung von mitochondrialen erkrankungen
DE60203702T2 (de) Verwendung eines adenosin-a3-rezeptor-agonisten zur hemmung der virenreplikation
DE69233115T2 (de) Weitere therapeutische Verwendungen von L-Methionine und Zusammensetzungen
US5268365A (en) Nucleotides, nucleosides, and nucleobases in immune function restoration enhancement or maintenance
WO1993016091A1 (de) Neue liponucleotide, deren herstellung sowie deren verwendung als antivirale arzneimittel
CH684310A5 (de) Substituierte Adeninderivate.
DD283938A5 (de) Verfahren zur herstellung von antineoplastisch wirksamen pharmazeutischen kombinationspraeparaten
Olusi et al. Plasma and white blood cell ascorbic acid concentrations in patients with bronchial asthma
CH681203A5 (sv)
DE69535453T2 (de) Zusammensetzungen zur Verbesserung der Immunantwort
CN113398144B (zh) 核苷酸混合物在制备预防或缓解老年肌少症制剂中的应用
DD261095A5 (de) Verfahren zur herstellung von antiviralen kombinationen
EP0374096B1 (de) 2',3'-Dideoxypurinnucleosid/Purinnucleosid-Phosphorylase-Inhibitor Kombinationstherapie und Zusammensetzungen dafür
SHANK et al. Studies on Diseases of Muscle: I. Progressive Muscular Dystrophy; A Clinical Review of Forty Cases
Kornberg et al. Granulocytopenia and anemia in rats fed diets of low casein content
Matsuishi et al. Childhood acid maltase deficiency: a clinical, biochemical, and morphologic study of three patients
DE69031694T3 (de) Glutamin zur Behandlung von beeinträchtigten Abwehrkräften
DE69631768T2 (de) Verwendung von l-carnitine und derivaten zur verminderung des ceramidspiegels und förderung der wirkung von antiretroviralen mitteln
Neumann et al. Requirement of the baby pig for vitamin B12 fed as a concentrate
DE2723451A1 (de) Polyribonucleotide, verfahren zu ihrer herstellung und ihre verwendung als oder in arzneimitteln
Ransome et al. Rare Form of Tuberculous Meningitis
Li et al. Modulation of DNA modification (I-compound) levels in rat liver and kidney by dietary carbohydrate, protein, fat, vitamin, and mineral content
Cooperman et al. Growth response and vitamin B12 tissue levels in vitamin B12-deficient rats and chicks fed riboflavin, 5, 6-dimethylbenzimidazole and related compounds
Foy et al. Response of megaloblastic anaemia of pregnancy to crystalline penicillin G
Haley et al. Comparison of Strophanthin-K and Tryptamine-Strophanthidin after Intra-ventricular Injection in Unanesthetized Dogs.

Legal Events

Date Code Title Description
PUE Assignment

Owner name: SANDOZ AG TRANSFER- BOARD OF REGENTS THE UNIVERSIT

PL Patent ceased